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Abstract
A Measurement Tool to Assess Systematic Reviews (AMSTAR) is a commonly used tool to assess the quality of
systematic reviews; however, modifications are needed to improve its usability, reliability, and validity. In this
commentary, we summarize our experience and the experiences of others who have used AMSTAR and provide
suggestions for its improvement. We propose that AMSTAR should modify a number of individual items and their
instructions and responses to make them more congruent with an assessment of the methodologic quality of
systematic reviews. We recommend adding new items and modifying existing items to assess the quality of the
body of evidence and to address subgroup and sensitivity analyses. More detailed instructions are needed for
scoring individual items across multiple reviewers, and we recommend that a total score should not be calculated.
These suggestions need to be empirically tested prior to implementation.
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Background
A Measurement Tool to Assess Systematic Reviews
(AMSTAR) is a commonly used tool to assess the
methodologic quality of systematic reviews [1]. It has
demonstrated satisfactory reliability and construct
validity [2] for systematic reviews of randomized
controlled trials of treatment interventions [3].
AMSTAR is widely used to assess the quality of systematic
reviews, and some users state it is the most appropriate
(and best) tool [4–6], while others have found it
problematic [7–17] and therefore modified the tool
[7, 11, 15, 18–30]. In this commentary, we summarize
our experience using AMSTAR along with the experiences
of others, describe several key issues, and provide sugges-
tions for improvement (Table 1).
Main text
The stated objective of AMSTAR is to assess the meth-
odological quality of systematic reviews [1] which refers
to whether the authors of a study (or presumably a
systematic review) did the best that they could [31]. The
items of AMSTAR, however, largely address quality of
reporting (e.g., items 5 and 6) [32] and risk of bias [33]
(e.g., items 8 and 9) rather than the methodological
quality. Several items should be amended to be consist-
ent with the stated objective.
AMSTAR encompasses most of the key constructs
that are relevant to the assessment of the metho-
dological quality of systematic reviews; however, one
critical construct is missing as noted also by other inves-
tigators [9, 34–36]: an explicit and reproducible method
for assessing the quality of the body of evidence for each
important outcome (i.e., the confidence in the estimates
of effect [37]). We suggest revising item 8 to focus on
this construct, separating it from the assessment of the
quality of individual studies (item 7) (Table 1). AMSTAR
also lacks an item that assesses subgroup and sensitivity
analyses [9, 36]. Subgroup analyses are important to
decision-makers as treatment effects may differ across
populations. Similarly, sensitivity analyses specified a
priori help to assess the robustness of the review’s
findings [31]. Items related to subgroups and sensitivity
analyses should be added (new item 12, Table 1).
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Table 1 Concerns regarding AMSTAR items, instructions, responses, and suggested revisions
AMSTAR toola Issues Suggested revisions










before the conduct of
the review.





objectives to score “yes.”
The phrase “a priori
design” is unclear.
Unless a protocol is
available or the authors
explicitly state that the
design was developed a
priori, a “yes” response is
not indicated; thus “cannot
answer” is likely the most
common response. Many
review authors state that
they developed the
research questions and
inclusion criteria prior to
executing the search;
however, according to the
instructions, a report of
such an approach would
still be “cannot answer” as















be established a priori as
evidenced by a published
protocol or an explicit
statement in the review.
Note: If the review refers









2. Was there duplicate
study selection and
data extraction?
There should be at
least two independent
data extractors and a
consensus procedure
for disagreements
should be in place.




process or one person
checks the other’s work.
None. The main sentence relates
to extraction only, and the
“note” relates to the other
aspects of the question.
The “note” is not clearly
written; for example, does
the consensus process





None. Reword: There should be
at least two independent
assessors for study
selection (i.e., title, abstract
and full-text screening).




data by a second person.
A consensus process
should be used when
disagreements arise in
either study selection at
the full-text stage or in
data extraction.Note: If
two independent people
do study selection and
data extraction is verified,
with consensus used in









At least two electronic
sources should be
searched. The report




This item should proceed













Reword: At least two
bibliographic databases
should be searched. The
report must include years
and databases examined
(e.g., Central, EMBASE, and
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and/or MESH terms









registers, or experts in
the particular field of
study, and by reviewing
the references in the
studies found.




or MESH terms must be






experts in the particular
field of study, and by
reviewing the references
in the studies found.
Publications in all relevant
languages should be
sought and a justification
provided when there are
language restrictions.
















or not they excluded





Note: If review indicates
that there was a search





and trial registries are all
considered gray for this
purpose. If searching a
source that contains
both gray and non-gray,
must specify that they
were searching for gray/
unpublished literature.
As written, this item is a
reporting issue and not
a quality issue. The item
implies that if publication
status was an inclusion
(or exclusion) criterion,




inclusion of gray literature.
The second sentence
suggests that the review
simply has to state if any
reports were excluded
based on publication type,
which is a reporting issue
and not a quality issue.
Language of publication






















to the research question.
Note: If the review
indicates that there








5. Was a list of
studies (included
A list of included and
excluded studies should
be provided.
None. Including a list of all
excluded studies may not




None. Reword: A list of included
and excluded studies at
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and excluded)
provided?
Note: Acceptable if the
excluded studies are
referenced. If there is an
electronic link to the list,
but the link is dead,
select “no.”
capabilities are available. It
is unclear at what stage
the excluded list is
focused; the full-text or the
title and abstract stage.
be available to the reader
(either within the
publication, in an online
appendix, or from the
review authors).
Note: If a list of both
included and excluded
studies (the latter at the
full-text stage) is
available either directly






In an aggregated form


















not in table format
as long as they are
described as above.
As written, this question
focuses on reporting
and not quality.
It should be emphasized
that the ranges of
characteristics should be





None. Reword: In summary
form, relevant data from
the individual studies
should be provided on
the participants, interventions,
comparators and outcomes.
Note: If the summary provides
the information necessary for
the reader to understand
the key characteristics of




7. Was the scientific
quality of the included
studies assessed and
documented?










as inclusion criteria); for
other types of studies
alternative items will
be relevant.
Note: Can include use
of a quality scoring tool
or checklist (e.g., Jadad
The meaning of “scientific
quality” is unclear. At the
individual study level, an
assessment of the risk of
bias is likely to be more
useful than consideration
of quality. It is also unclear
if this item refers to the
individual study or to the
body of evidence.
The meaning of the phrase
a priori methods of
assessment” is unclear. The
tools used to assess risk of
bias should be reliable,
valid and tailored to the






they require each item to
be weighted relative to
other items.














Reword: At least two authors
should assess the risk of bias
using an instrument
appropriate to the study
design and context. A
consensus process should
be used to determine the
final assessment. The risk
of bias should be reported
for each study. Quality
scores should not be used;
categories such as high,
moderate, and
low are preferred.
Note: If the risk of bias of
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scale, risk of bias,
sensitivity analysis, etc.),
or a description of
quality items with some
kind of result for each
study (“low” or “high” is
fine, as long as it is clear
which studies scored





not a type of quality
tool or checklist.
appropriately assessed
and reported, score “yes.”
















something such as “the
results should be
interpreted with caution
due to poor quality of
included studies.”
Cannot score “yes” for
question if scored “no”
for question 7.







scientific quality is unclear;
and additional guidance is




refers only to conclusions;
however the instructions
refer to both analysis and
conclusions. It is unclear
how quality should be
considered in analyses.


























Note: Score “yes” if the
review authors appropriately
considered the quality of
the body of evidence
(across studies) for each
important and critical





9. Were the methods
used to combine the
findings of studies
appropriate?
For the pooled results, a
test should be done to
ensure the studies were
combinable, to assess
their homogeneity (i.e.,
χ2 test for homogeneity,
I2). If heterogeneity
exists a random effects





(i.e. is it sensible
to combine?).
Note: Indicate “yes”
if they mention or
The item addresses the
method for combining
studies, yet the instructions








the latter should always
be performed first. Tests
for heterogeneity do not
“ensure the studies were
combinable.”














If a meta-analysis was
performed, it should have
been performed in an
appropriate manner.
Note: Score “yes” if the
qualitative synthesis is
appropriate, if heterogeneity
was explored, and if a
meta-analysis was













Table 1 Concerns regarding AMSTAR items, instructions, responses, and suggested revisions (Continued)
describe heterogeneity
(i.e., if they explain but
cannot pool because of
heterogeneity/variability
between interventions.











test).Note: If no test
values or funnel plots
included, score “no.”
Score “yes” if mentions
that publication bias
could not be assessed
because there were
fewer than 10 included
studies.
None. These tests examine the
issue of small study bias,
not publication bias per se.
Often more important
than graphical and
statistical tests in exploring
publication bias is














assessed as part of




None. Reword: The potential for
publication bias should have
been considered in the review,
using other information as
relevant, and graphical aids
and statistical tests as
appropriate. The limitations
of the statistical and
graphical tests should be
noted in the review.
Note: A “yes” response
can be used if the review
authors explored the data
and other relevant
information sources for
evidence of small study
or publication bias. A
“not applicable” response
should be used if
publication bias was
considered as part of
quality assessment of the
body of evidence in item 8.
None.






review and the included
studies.
Note: To get a “yes,”
must indicate source
of funding or support
for the systematic
review AND for each
of the included studies.
The phrase “conflict of
interest” is unclear. This
likely refers to whether
there is a disclosure of
conflicts, but it is unclear
whether this refers to
individual authors of the
review and/or included
studies or to the funder
of the review and/or
included studies.
The instructions are not
congruent with the item.
“Sources of support” could
refer to funding for the
review, financial support
for the review authors, or
funding of the included
studies. Conflict of interest
includes other interests
that may interfere with the
















relevant interests should be
provided for all review
authors and the source of
funding for the review
and for each study
included in the review
should be reported.
Note: “Yes” is indicated if
disclosures of interest are
provided for all review
authors, the funding for
the review is provided
and is not likely to be a
source of bias to the
review’s conclusions,
and the funding for all
included studies is
indicated (or if not
reported in the
individual studies
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be considered in the
scope and in the key
questions for the review,
and in searching, data
extraction and analysis
and in the review’s
conclusions.
Note: “Yes” is indicated



















Some AMSTAR items and their instructions are
unclear and need to be revised (Table 1). For example,
item 4 regarding the “status of publication” might refer
to either the inclusion or exclusion of gray literature.
The instructions suggest that gray literature should be
included; however, its relevance is closely related to the
review question and may not always be necessary. In
AMSTAR [1], foreign language publications are consid-
ered gray literature; however, this is not consistent with
commonly used definitions [38].
The response options (yes, no, cannot answer, not
applicable) are problematic [9, 39–43]. For example,
“cannot answer” can be difficult to interpret and distin-
guish from “no” when no information is provided. A
common approach to quality assessment is to assume
that if the authors did not report a step, then it did not
happen; thus, “no” would be the appropriate response.
The instructions, however, suggest that “cannot answer”
should be used when the item is “relevant but not
described,” which means a “no” response would rarely
be used as authors seldom report explicitly that they did
not do something. In addition, “not applicable” is only
appropriate to two items (items 9 and 10) when these
items are not possible or appropriate; all other items
should always be addressed.
The guidance for scoring individual items and for
obtaining a total score is unclear. In AMSTAR [1], if all
criterion are met for an individual item (i.e., “yes”), it
receives a score of “1” and the sum of all “yes” responses
indicates the total score out of 11. Systematic reviews,
however, often partially meet the item’s criteria such as
listing the search databases and dates but, perhaps due
to word limitations of the journal, do not provide the
search strategies or keywords. To address the issue of
evaluating multiple constructs within a single AMSTAR
item, investigators have modified its scoring to allow
points for partially fulfilled items [7, 9, 34, 35, 39]. Kung
and colleagues developed R-AMSTAR [44], subdividing
each item into four components with a score ranging
from 11 to 44, where higher scores indicate better
methodological quality. R-AMSTAR has been used by
a number of investigators [5, 45–50], and a compari-
son to AMSTAR concluded that R-AMSTAR provided
greater guidance for each item and is more reliable
and useful [51].
In addition, AMSTAR provides no guidance on how to
combine individual item scores from multiple assessors
other than stating that consensus should be reached for
each item. We have averaged AMSTAR scores across
assessors to encompass each independent evaluation [52].
Other investigators have used similar approaches such as
averaging scores between two assessors when discordant
by one or two points and involving a third assessor when
scores differed by three or more points [53, 54].
AMSTAR was deliberately developed without guidance
on how to translate the total score into categorical
ratings for the overall assessment of the systematic
review’s quality (e.g., good, fair, poor) [1, 55]. Various
thresholds have been used by investigators to define
categories for quality (e.g., 0–4 vs. 0–3 for poor quality),
making it difficult to compare assessments across
reviews. AMSTAR was also designed under the as-
sumption that each item is of equal weight when
considering the systematic review’s overall quality [2].
Other investigators have dealt with this issue by
assigning different weights to items they consider
more important [53, 56–58]. For example, Jacobs and
colleagues rated systematic reviews as high quality if
items 3, 6, 7, and 8 were met regardless of the total
score [57]. An additional problem with the current
scoring method is the equivalence of “not applicable,”
“no,” and “cannot answer” (all scored as zero) because
an item rated as “not applicable” should not be taken
into account in the total score. Clearer guidance about
calculating a total score is needed along with an acknow-
ledgement of the limitations of scoring across all items
should users of AMSTAR choose to calculate a total score.
We believe that obtaining a total score should be avoided
as it has been shown to be problematic [59].
Conclusion
AMSTAR is a useful tool for assessing the quality of
systematic reviews; however, some modifications would
improve its usability, reliability, and validity. The issues
discussed in this commentary are not limited to our own
experiences but are shared across many investigators
who have used this tool. We have provided suggestions
for improving AMSTAR; however, any revised tool needs
to be empirically tested for reliability and validity, and
undoubtedly, additional refinements will be needed. We
look forward to further dialog on AMSTAR and to
subsequent revisions and evaluations.
Abbreviation
AMSTAR: A Measurement Tool to Assess Systematic Reviews.
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